Laya Kiani
Laya Kiani is a blogger at CCRM, focusing on creating content about the market analysis of regenerative medicine. With over four years of experience in health care and marketing across Canada, Dubai and Iran, she brings a diverse perspective to her work. Laya holds a B.Sc. in Pharmaceutical Chemistry from the University of Guelph. Connect with her on LinkedIn: LayaKiani
Posts by: Laya
Navigating regulatory challenges and advancements in the RM market
The regenerative medicine (RM) market is highly competitive, with major biopharmaceutical companies and innovative startups vying for dominance. As companies seek regulatory approval and work to establish their presence in this fast-evolving industry, the competitive landscape remains dynamic and ever-changing. Market growth is significantly driven by promising clinical trial outcomes and increasing investments in cutting-edge […]
The role and impact of IP rights on innovation and investment in RM
Intellectual property (IP) rights in regenerative medicine (RM) are crucial for sparking innovation and staying ahead in a competitive market. Protecting inventions through patents and other IP rights encourages investment by giving inventors exclusive market rights. This also ensures that new advancements are eventually disseminated widely. Patents grant an exclusive monopoly for a set period […]
Economic impact and comprehensive cost-benefit analysis of RM
According to the World Health Organization (WHO), in 2017, total global spending on health reached US$7.8 trillion and, by 2020, this figure had leapt to $9 trillion as governments raced to contain the first wave of COVID-19. The WHO estimates that worldwide spending on health in 2020 amounted to 10.8 per cent of the gross […]